Artículo

Ghrelin proteolysis increases in plasma of men, but not women, with obesity

Fittipaldi, Antonela Soledad Icon; Castrogiovanni, Daniel Cayetano Icon; Lufrano, Daniela Icon; Saenz, Camila Icon; de Francesco, Pablo Nicolás Icon; Lalonde, Tyler ; Luyt, Leonard G. ; Cantel, Sonia ; Fehrentz, Jean Alain ; Andreoli, Maria Florencia Icon; Perello, Mario Icon

Otros responsables

Fecha

01/2023

Editorial

Pergamon-Elsevier Science Ltd

Revista

Life Sciences

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0024-3205

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Aims: Since plasma ghrelin can undergo des-acylation and proteolysis, the aim of this study was to investigate the extent to which an enhancement of these reactions is associated to the decrease of ghrelin in plasma after food intake or in individuals with obesity. Main methods: we performed an intervention cross-sectional study, in which levels of ghrelin, desacyl-ghrelin (DAG), glucose, insulin, ghrelin des-acylation and ghrelin proteolysis were assessed in plasma before and after a test meal in 40 people (n = 21 males) with normal weight (NW, n = 20) or overweight/obesity (OW/OB, n = 20). Key findings: Preprandial ghrelin and DAG levels were lower, whereas preprandial ghrelin proteolysis was ∼4.6-fold higher in plasma of males with OW/OB. In males, ghrelin proteolysis positively correlated with glycemia. Ghrelin and DAG levels were also lower in females with OW/OB, but preprandial ghrelin proteolysis was not different between females with NW or OW/OB. Ghrelin and DAG levels decreased postprandially in males and females, independently of BMI, and ghrelin proteolysis increased postprandially ∼2 folds only in individuals with NW. Ghrelin des-acylation remained unaffected by BMI or feeding status in both sexes. Significance: Current study shows that ghrelin proteolysis increases in males with obesity as well as after meal in lean individuals. Therefore, ghrelin proteolysis may be an important checkpoint and, consequently, a putative pharmacological target to control circulating ghrelin levels in humans.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa